Immunocore Holdings (IMCR) Earnings Date & Reports
Immunocore Holdings PLC is a commercial-stage biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IMCR is expected to report earnings to fall 325.20% to -22 cents per share on August 06
Q2'25
Est.
$-0.23
Q1'25
Beat
by $0.49
Q4'24
Missed
by $0.23
Q3'24
Beat
by $0.50
Q2'24
Beat
by $0.25
The last earnings report on May 07 showed earnings per share of 10 cents, beating the estimate of -38 cents. With 541.17K shares outstanding, the current market capitalization sits at 1.43B.